{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:30:04Z","timestamp":1766158204272,"version":"3.41.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,2]],"date-time":"2018-06-02T00:00:00Z","timestamp":1527897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.cca.2018.06.001","type":"journal-article","created":{"date-parts":[[2018,6,2]],"date-time":"2018-06-02T15:47:24Z","timestamp":1527954444000},"page":"226-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Urinary N-terminal fragment of titin is a marker to diagnose muscular dystrophy in patients with cardiomyopathy"],"prefix":"10.1016","volume":"484","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5574-6617","authenticated-orcid":false,"given":"Akiomi","family":"Yoshihisa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatoyo","family":"Kiko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamasa","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Oikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuchika","family":"Takeishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2016","key":"10.1016\/j.cca.2018.06.001_bb0005","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart J."},{"issue":"2013","key":"10.1016\/j.cca.2018.06.001_bb0010","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2018.06.001_bb0015","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Force m","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2018.06.001_bb0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.carpath.2011.10.001","article-title":"2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology","volume":"21","author":"Leone","year":"2012","journal-title":"Cardiovasc. Pathol."},{"issue":"2011","key":"10.1016\/j.cca.2018.06.001_bb0025","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.jacc.2011.06.011","volume":"58","author":"Gersh","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2018.06.001_bb0030","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/hrt.2008.161166","article-title":"The role of endomyocardial biopsy in the management of cardiovascular disease: a commentary on joint AHA\/ACC\/ESC guidelines","volume":"95","author":"Elliott","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.cca.2018.06.001_bb0035","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the European Society of Cardiology working group on myocardial and pericardial diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2018.06.001_bb0040","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1093\/eurheartj\/ehm456","volume":"28","author":"Cooper","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2018.06.001_bb0045","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.jacc.2016.02.081","article-title":"Dystrophin-deficient cardiomyopathy","volume":"67","author":"Kamdar","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2018.06.001_bb0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/cvr\/cvv021","article-title":"Dystrophic cardiomyopathy: role of TRPV2 channels in stretch-induced cell damage","volume":"106","author":"Lorin","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cca.2018.06.001_bb0055","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.yjmcc.2009.01.004","article-title":"Titin-based mechanical signalling in normal and failing myocardium","volume":"46","author":"Kruger","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.cca.2018.06.001_bb0060","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/hmg\/ddt494","article-title":"Recessive TTN truncating mutations define novel forms of core myopathy with heart disease","volume":"23","author":"Chauveau","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cca.2018.06.001_bb0065","doi-asserted-by":"crossref","first-page":"30304","DOI":"10.1074\/jbc.M110.108720","article-title":"Interactions with M-band titin and calpain 3 link myospryn (CMYA5) to tibial and limb-girdle muscular dystrophies","volume":"285","author":"Sarparanta","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2018.06.001_bb0070","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/342380","article-title":"Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin","volume":"71","author":"Hackman","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cca.2018.06.001_bb0075","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bbrc.2003.11.101","article-title":"Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy","volume":"313","author":"Hayashi","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2018.06.001_bb0080","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ng.3719","article-title":"Titin-truncating variants affect heart function in disease cohorts and the general population","volume":"49","author":"Schafer","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cca.2018.06.001_bb0085","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ejhf.673","article-title":"Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy","volume":"19","author":"Jansweijer","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.cca.2018.06.001_bb0090","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10741-005-5252-6","article-title":"Sarcomeric protein mutations in dilated cardiomyopathy","volume":"10","author":"Chang","year":"2005","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.cca.2018.06.001_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/srep39375","article-title":"Establishment of a highly sensitive sandwich ELISA for the N-terminal fragment of titin in urine","volume":"6","author":"Maruyama","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2018.06.001_bb0100","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.nmd.2014.03.012","article-title":"Proteomics profiling of urine reveals specific titin fragments as biomarkers of Duchenne muscular dystrophy","volume":"24","author":"Rouillon","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.cca.2018.06.001_bb0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.euje.2005.12.014","article-title":"Recommendations for chamber quantification","volume":"7","author":"Lang","year":"2006","journal-title":"Eur. J. Echocardiogr."},{"key":"10.1016\/j.cca.2018.06.001_bb0110","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.cca.2018.06.001_bb0115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10741-005-5251-7","article-title":"Titin: physiological function and role in cardiomyopathy and failure","volume":"10","author":"Granzier","year":"2005","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.cca.2018.06.001_bb0120","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1093\/hmg\/ddu366","article-title":"Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients","volume":"23","author":"Hathout","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cca.2018.06.001_bb0125","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.1073\/pnas.1507719112","article-title":"Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy","volume":"112","author":"Hathout","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cca.2018.06.001_bb0130","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.nmd.2008.08.005","article-title":"Calpain 3, the \"gatekeeper\" of proper sarcomere assembly, turnover and maintenance","volume":"18","author":"Beckmann","year":"2008","journal-title":"Neuromuscul. Disord."},{"issue":"2015","key":"10.1016\/j.cca.2018.06.001_bb0135","doi-asserted-by":"crossref","first-page":"805172","DOI":"10.1155\/2015\/805172","article-title":"Role of inflammation in muscle homeostasis and myogenesis","author":"Costamagna","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cca.2018.06.001_bb0140","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1152\/physrev.00017.2009","article-title":"Muscle giants: molecular scaffolds in sarcomerogenesis","volume":"89","author":"Kontrogianni-Konstantopoulos","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cca.2018.06.001_bb0145","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fphys.2016.00076","article-title":"Titin, a central mediator for hypertrophic signaling, exercise-induced Mechanosignaling and skeletal muscle remodeling","volume":"7","author":"Kruger","year":"2016","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cca.2018.06.001_bb0150","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cca.2017.11.024","article-title":"Diagnostic and clinical significance of the titin fragment in urine of Duchenne muscular dystrophy patients","volume":"476","author":"Awano","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2018.06.001_bb0155","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/archneur.1961.00450110050006","article-title":"Serum creatine phosphokinase. Activity in progressive muscular dystrophy and neuromuscular diseases","volume":"4","author":"Okinaka","year":"1961","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.cca.2018.06.001_bb0160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/mus.23810","article-title":"Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy","volume":"48","author":"Mendell","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cca.2018.06.001_bb0165","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ejhg.2012.301","article-title":"Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK)","volume":"21","author":"Moat","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.cca.2018.06.001_bb0170","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1148\/radiol.10091547","article-title":"T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments","volume":"255","author":"Kim","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.cca.2018.06.001_bb0175","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/clinchem\/37.1.36","article-title":"Carbonic anhydrase III in serum in muscular dystrophy and other neurological disorders: relationship with creatine kinase","volume":"37","author":"Ohta","year":"1991","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2018.06.001_bb0180","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0022-510X(81)90118-0","article-title":"Serum myoglobin in muscular dystrophy and carrier detection","volume":"51","author":"Nicholson","year":"1981","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cca.2018.06.001_bb0185","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.nmd.2011.05.011","article-title":"Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD)","volume":"21","author":"Nadarajah","year":"2011","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.cca.2018.06.001_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080263","article-title":"Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular dystrophy","volume":"8","author":"Zaharieva","year":"2013","journal-title":"PLoS One"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898118302870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898118302870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T23:17:14Z","timestamp":1751671034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898118302870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":38,"alternative-id":["S0009898118302870"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2018.06.001","relation":{},"ISSN":["0009-8981"],"issn-type":[{"type":"print","value":"0009-8981"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary N-terminal fragment of titin is a marker to diagnose muscular dystrophy in patients with cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2018.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}